TGFS Start

Realize creative ideas
with us.
Turn capital and know-how
into success.

About us

TGFS is an equity investor for knowledge-based, technology-oriented start-ups in the federal state of Saxony. It is the leading start-up investor in Saxony and provides teams in the seed and start-up phases with venture capital and management support. Moreover, an investment by TGFS opens up access to further international investors from the fund’s network.

The fund was first launched in 2008 by the Free State of Saxony (including ERDF funds) and Saxon financial institutions and has since supported more than 100 start-ups in its third generation of funds.

Invests in Saxony
since 2008

Status
third fund generation
€241.2m total volume

Learn More

Investment stages

TGFS is a venture capital fund active in Saxony. We support founders and start-ups in the technology sector with equity and years of experience. We also invest in early stages, if we are convinced of the idea and the team.

Start-up
Seed phase

TGFS invests in start-ups and early-stage companies in Saxony and accompanies them in realising their vision.

Learn More

years operating in Saxony

years
operating in Saxony

years of investment experience

realised transactions

€ million investment volume

News

in.hub schließt erfolgreich eine neue Finanzierungsrunde ab

in.hub successfully completes new financing round

21. October 2025

in.hub GmbH, a leading provider of plug-and-play IIoT solutions, has completed a seven-figure add-on financing round. In addition to TGFS, SBG is also participating for the first time as part of the Saxony Innovation Capital (RIG) program.

Packwise secures seven-figure growth capital

30. July 2025

Packwise GmbH, based in Dresden, has successfully completed a seven-figure financing round. In addition to existing investors TGFS and Hüttenes³, SBG — Sächsische Beteiligungsgesellschaft is also participating for the first time via the RegioInnoGrowth program (RIG).

bmp and TGFS invest in CYNiO

9. July 2025

Chemistry startup CYNiO has raised over €2 million in capital to scale up its CO₂-based, phosgene-free technology for producing isocyanates. The innovation enables safe, flexible production, even of small batches, for applications in the pharmaceutical, agricultural, and construction industries.